Cryolife Inc: (NYSE: CRY)
$6.34
0.03 (0.48%)
Volume 60,387
May 17 04:06 PM ET
Zacks Rank: 2-Buy 
| #2 |
Overview Quote
Stock Activity
| Day Low - High | 6.26 - 6.35 |
| 52wk Low - High | 4.19 - 7.27 |
| Previous Close | 6.31 |
| Avg. Volume | 74,181 |
| Industry | MED INSTRUMENTS |
| Market Cap | 174.24 M |
| Div - Yield | 0.10 - 1.58 |
| Beta | 1.03 |
| PE (Forward) | 22.38 |
| Current Year Est. | 0.28 |
| Quarterly Earnings ESP |
NA |
Premium research
Zacks Rank
|
 2 |
Zacks Recommendation
|
Neutral |
Zacks Industry Rank
|
114 out of 265 |
Equity Research Report
|
PREMIUM |
( = Change in last 30 days)
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial
Key Earnings Data
| PE (Forward) | 22.38 |
| PEG Ratio | 5.59 |
| Current Year Est. | 0.28 |
| Current Quarter Estimate | 0.07 |
| Most Accurate Estimate | NA |
| Earnings ESP |
NA |
| Next Earnings Report Date | 08-06-2013 |
| EPS Last Year | 0.35 |
| Expected Earnings Growth | 4.00% |
Company Description
CryoLife, Inc. is the leader in the development and commercialization of implantable living human tissues for use in cardiovascular, vascular, and orthopaedic surgeries throughout the United States and Canada. The company's BioGlue surgical adhesive, the company marked in the European Union for use in vascular and pulmonary sealing and repair, is distributed throughout Europe. The company also manufactures CryoLife- O'Brien and CryoLife-Ross stentless porcine heart valves which are distributed within the European Community. (PRESS RELEASE)
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Turn Earnings Surprises into quick profits.
Earnings Estimates
| Current Qtr (06/2013) |
Next Qtr (09/2013) |
Current Year (12/2013) |
Next Year (12/2014) |
|
|---|---|---|---|---|
| Average Estimate | 0.07 | 0.07 | 0.28 | 0.42 |
| Number of Estimates | 1 | 1 | 3 | 1 |
| Low Estimate | 0.07 | 0.07 | 0.28 | 0.42 |
| High Estimate | 0.07 | 0.07 | 0.29 | NA |
| Year Ago EPS | 0.10 | 0.08 | 0.34 | 0.28 |
| EPS Growth | -30.00% | -12.50% | -16.67% | 48.24% |
Industry Analysis
| Name | Symbol | Previous Close | Zacks Rank | Zacks Recommendation |
|---|---|---|---|---|
| CRYOLIFE INC | CRY | 6.34 | |
|
| NATUS MEDICAL | BABY | 14.36 | |
|
| DELCATH SYS INC | DCTH | 0.41 | |
|
| GLOBUS MEDICAL | GMED | 15.69 | |
|
| HEARTWARE INTL | HTWR | 99.19 | |
|
| MELA SCIENCES | MELA | 1.07 | |
|
| OXYSURE SYSTEMS | OXYS | 0.90 | |
|
| PACIFIC BIOSCI | PACB | 2.42 | |
|
| SUNSHINE HEART | SSH | 5.49 | |
|
| ABIOMED INC | ABMD | 23.33 | |
|
Sector:Medical>> Industry:MED INSTRUMENTS
COMPARE TICKER vs. Its Peers
Zacks Commentary
Financials
| EPS TTM | 0.35 |
| Sales | 132 |
| Net Income | 9 |
| Price/Earnings | 18.11 |
| Price/Book | 1.35 |
| Price/Cash Flow | 11.43 |
| Price/Sales | 1.29 |
News
Shares of CryoLife Under Pressure, Down 1.4% - Financial News Network Online - Market Movers
May 15, 2013
CryoLife reports higher Q1 net income, provides outlook for 2013 - Datamonitor
May 10, 2013
Stock Investors Bid Up Shares of CryoLife, Up 2.5% - Financial News Network Online - Market Movers
May 7, 2013
CryoLife, Inc.Corporate Event Announcement Notice - Wall Street Horizon
May 1, 2013
CryoLife 2013 First Quarter Revenues Grew 10 Percent to a Record $35.5 Million - Pr Newswire
Apr 30, 2013
CryoLife Reaffirms - Earningswhispers Earnings Guidance
Apr 30, 2013
CryoLife, Inc.Corporate Event Announcement Notice - Wall Street Horizon
Apr 30, 2013
CryoLife Shares Climbing Higher, Up 2.4% - Financial News Network Online - Market Movers
Apr 29, 2013
Broker Recommendations
| Current ABR | 2.00 |
| ABR (Last Week) | 2.00 |
| # of recs in ABR | 4 |
| Average Target Price | 6.92 |
| Industry Rank by ABR | 114 out of 265 |
| Rank in Industry | 2 out of 52 |
